SEARCH

SEARCH BY CITATION

References

  • 1
    Stirrat GM : Recurrent miscarriage: definition and epidemiology. Lancet 1990; 336:673675.
  • 2
    Stirrat GM : Recurrent miscarriage II-Clinical associations, causes, and management. Lancet 1990; 336:728733.
  • 3
    Carrington B , Sacks G , Regan L : Recurrent miscarriage: pathophysiology and outcome. Curr Opin Obstet Gynecol 2005; 17:591597.
  • 4
    Pandey MK , Rani R , Agrawal S : An update in recurrent spontaneous abortion. Arch Gynecol Obstet 2005; 272:95108.
  • 5
    Rai R , Regan L : Recurrent miscarriage. Lancet 2006; 368:601611.
  • 6
    Miyakis S , Lockshin MD , Atsumi T , Branch DW , Brey RL , Cervera R , Derksen RH , De Groot PG , Koike T , Meroni PL , Reber G , Shoenfeld Y , Tincani A , Vlachoyiannopoulos PG , Krilis SA : International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295306.
  • 7
    Goddjin M , Leschot NJ : Parental chromosome testing. In Early Pregnancy. RG Farquharson , MD Stephenson (eds). Cambridge, Cambridge University Press, 2010, pp 91102.
  • 8
    Royal College of Obstetricians and Gynecologist (RCOG). The investigation and treatment of couples with recurrent spontaneous miscarriage. Guidelines no 17. May 2003. 1–13.
  • 9
    Redecha P , Tilley R , Tencati M , Salmon JE , Kirchhofer D , Mackman N , Girardi G : Tissue factor: a link between C5a and neutrophile activation in antiphospholipid antibody-induced fetal injury. Blood 2007; 110:24232431.
  • 10
    Ticconi C , Giuliani E , Veglia M , Pietropolli A , Piccione E , Di Simone N : Thyroid autoimmunity and recurrent miscarriage. Am J Reprod Immunol 2011; 66:452459.
  • 11
    Thangaratinam S , Tan A , Kilby MD : Thyroid autoimmunity and recurrent miscarriage. BMJ 2011; 342:d2616. doi:10.1136/bmj.d2616.
  • 12
    Kuperman A , Micco PD , Brenner B : Fertility, infertility and thrombophilia. Women′s Health 2011; 7:545553.
  • 13
    Wegmann TG , Lin H , Guilbert L , Mossmann TR : Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14:353356.
  • 14
    Clark DA , Arck PC , Chaouat G : Why did your mother reject you? Immunogenetic determinants of the response to environmental selective pressure expressed at the uterine level. Am J Reprod Immunol 1999; 41:522.
  • 15
    Thellin O , Coumans B , Zorzi W , Igout A , Heinen E : Tolerance to the foeto-placental graft: ten ways to support a child for nine months. Curr Opin Immunol 2000; 12:731737.
  • 16
    Levi M , van der Poll T : Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 2005; 15:254259.
  • 17
    Li M , Huang J : Innate immunity, coagulation and placenta -related adverse pregnancy outcomes. Thromb Res 2009; 124:656662.
  • 18
    Jauniaux E , Farquharson RG , Christiansen OB , Exalto N : Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod 2006; 21:22162222.
  • 19
    Van Den Boogaard E , Hermens RP , Leschot NJ , Baron R , Vollebergh JH , Bernardus RE , Van Der Veen F , Kremer JA , Goddijn M : Identification of barriers for good adherence to a guideline on recurrent miscarriage. Acta Obstet Gynecol Scand 2011; 90:186191.
  • 20
    Porter TF , Scott JR : Evidence-based care of recurrent miscarriage. Best Pract Res Clin Obstet Gynecol 2005; 19:85101.
  • 21
    Stephenson M , Kutteh W : Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol 2007; 50:132145.
  • 22
    Norwich ER , Schust DJ , Fisher SJ : Implantation and the survival of early pregnancy. NEJM 2001; 345:14001408.
  • 23
    Moffett-King A : Natural Killer cells and pregnancy. Nat Rev 2002; 2:656663.
  • 24
    Karimi K , Blois SM , Arck PC : The upside of natural killers. Nat Med 2008; 14:11841185.
  • 25
    Bischof P , Campana A : A model for implantation of the human blastocyst and early placentation. Hum Reprod Update 1996; 2:262270.
  • 26
    Red-Horse K , Zhou Y , Genbacev O , Prakobphol A , Foulk R , McMaster M , Fisher SJ : Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface. J Clin Invest 2004; 114:744754.
  • 27
    Kalkunte S , Lai Z , Tewari N , Chichester C , Romero R , Padbury J , Sharma S : In-vitro and in-vivo evidence for lack of endovascular remodelling by third trimester trophoblasts. Placenta 2008; 29:871878.
  • 28
    Kalkunte S , Boij R , Norris W , Friedman J , Lai Z , Kurtis J , Lim KH , Padbury JF , Matthiesen L , Sharma S : Serum from preeclampsia patients elicits symptoms of human disease in mice and provides a basis for an in vitro predictive assay. Am J Pathol 2010; 177:23872397.
  • 29
    Aluvihara VR , Kallikourdis M , Betz AG : Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5:266271.
  • 30
    Mjösberg J , Berg G , Ernerudh J , Ekerfelt C : CD4+ CD25+ regulatory T cells in human pregnancy: development of a Treg-MLC-ELISPOT suppression assay and indications of paternal specific Tregs. Immunology 2007; 120:456466.
  • 31
    Kalkunte S , Mselle TF , Norris WE , Wira CR , Sentman CL , Sharma S : Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J Immunol 2009; 182:40854092.
  • 32
    Kwak-Kim J , Yang KM , Gilman-Sachs A : Recurrent pregnancy loss: a disease of inflammation and coagulation. J Obstet Gynecol Res 2009; 35:609622.
  • 33
    Rai R , Backos M , Baxter N , Chilcott I , Regan L : Recurrent miscarriage – an aspirin a day? Hum Reprod 2000; 15:22202223.
  • 34
    Dolitzky M , Inbal A , Segal Y , Weiss A , Brenner B , Carp H : A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages. Fertil Steril 2006; 86:362366.
  • 35
    Badawy AM , Khiary M , Sherif LS , Hassan M , Ragab A , Abdelall I : Low-molecular weight heparin in patients with recurrent early miscarriages of unknown etiology. Obstet Gynecol 2008; 28:280284.
  • 36
    Fawzy M , Shokeir T , El-Tatongy M , Warda O , El-Refaiey AA , Mosbah A : Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study. Arch Gynecol Obstet 2008; 278:3338.
  • 37
    Laskin CA , Spitzer KA , Clark CA , Crowther MR , Ginsberg JS , Hawker GA , Kingdom JC , Barrett J , Gent M : Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA trial. J Rheumatol 2009; 36:279287.
  • 38
    Kaandorp SP , Goddijn M , van der Post JA , Hutten BA , Verhoeve HR , Hamulyák K , Mol BW , Folkeringa N , Nahuis M , Papatsonis DN , Büller HR , van der Veen F , Middeldorp S : Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010; 362:15861596.
  • 39
    Clark P , Walker ID , Langhorne P , Crichton L , Thomson A , Greaves M , Whyte S , Greer IA : Scottish Pregnancy Intervention Study (SPIN) collaborators: SPIN (Scottish pregnancy intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood 2010; 115:41624167.
  • 40
    Visser J , Ulander VM , Helmerhorst FM , Lampinen K , Morin-Papunen L , Bloemenkamp KW , Kaaja RJ : Thromboprophylaxis for recurrent miscarriage in women with and without thrombophilia. HABENOX: a randomised muliticentre trial. Thromb Haemost 2011; 105:295301.
  • 41
    Mantha S , Bauer KA , Zwicker JI : Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: a systemic review. J Thromb Haemost 2010; 8:263268.
  • 42
    Schusts DJ , Andelin CO : Immunology of isolated and recurrent spontaneous pregnancy loss. Glob Libr Women′s Med 2008; ISSN: 1756-2228; DOI 10.3843/GLOWM.10320.
  • 43
    Bajekal N , Li TC : Fibroids, infertility and pregnancy wastage. Hum Reprod Update 2000; 6:614620.
  • 44
    Salim R , Woelfer B , Backos M , Regan L , Jurkovic D : Reproducibility of three dimensional ultrasound diagnosis of congenital uterine anomalies. Ultrasound Obstet Gynecol 2003; 21:578582.
  • 45
    Farquharson RG , QUenby S , Greaves M : Antiphospholipid syndrome in pregnancy: a randomized, conrolled trial of treatment. Obstet Gynecol 2002; 100:408413.
  • 46
    Empson M , Lassere M , Craig JC , Scott JR : Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005; 2:175. CD002859.
  • 47
    Middeldorp S , Goddjin M : Recurrent miscarriage and thrombophilia. Dutch Med J 2006; 150:189193.
  • 48
    Ball E , Robson SC , Ayis S , Lyall F , Bulmer JN : Early embryonic demise: no evidence of abnormal spiral artery transformation on trophoblast invasion. J Pathol 2006; 208:528534.
  • 49
    Ball E , Bulmer JN , Ayis S , Lyall F , Robson SC : Late sporadic miscarriage is associated with abnormalities in spiral artery transformation and trophoblast invasion. J Pathol 2006; 208:535542.
  • 50
    Quenby S , Mountfield S , Cartwright JE , Whitley GS , Vince G : Effects of Low-Molecular-Weight and unfractionated heparin on trophoblast function. Obstet Gynecol 2004; 104:354361.
  • 51
    Nelson SM , Greer IA : The potential role of heparin in assisted conception. Hum Reprod Update 2008; 14:623645.
  • 52
    Laskin CA , Bombardier C , Hannah ME , Mandel FP , Ritchie JW , Farewell V , Farine D , Spitzer K , Fielding L , Soloninka CA , Yeung M : Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997; 337:148153.
  • 53
    Choi BC , Polgar K , Xiao L , Hill JA : Progesterone inhibit in-vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod 2000; 15(Suppl 1):4659.
  • 54
    Haas DM , Ramsey PS : Progesterone for preventing miscarriage. Cochrane Database Syst Rev 2008; 2:137. CD003511.
  • 55
    Dwyer JM : Manipulating the immune system with immune globulin. N Engl J Med 1992; 326:107116.
  • 56
    Thornton CA , Ballow M : Safety of intravenous immunoglobulin. Arch Neurol 1993; 50:135136.
  • 57
    Coulam CB , Krysa L , Stern JJ , Bustillo M : Intravenous immunoglobulin for treatment of recurrent pregnancy loss. Am J Reprod Immunol 1995; 34:333337.
  • 58
    Christiansen OB : Intravenous immunoglobulin in the prevention of recurrent spontaneous abortion: the European experience. Am J Reprod Immunol 1998; 39:7781.
  • 59
    Stephenson MD , Dreher K , Houlihan E , Wu V : Prevention of recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, double-blinded, placebo-controlled trial. Am J Reprod Immunol 1998; 39:8288.
  • 60
    Sjöblom C , Wikland M , Robertson SA : GM-CSF acts independently of the beta common subunit of the GM-CSF receptor to prevent inner cell mass apoptosis in human embryos. Biol Reprod 2002; 67:18171823.
  • 61
    Shapiro BS , Richter KS , Daneshmand ST , Quinn P , Behr B : GM-CSF enhances human embryo development to the blastocyst stage: a randomized study. Fertil Steril 2003; 79(Suppl 2):1516.
  • 62
    Segerer S , Kammerer U , Kapp M , Dietl J , Rieger L : Upregulation of chemokine and cytokine production during pregnancy. Obstet Gynecol Invest 2009; 67:145150.
  • 63
    Perricone R , De Carolis C , Giacomelli R , Guarino MD , De Sanctis G , Fontana L : GM-CSF and pregnancy: concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment. Am J Reprod Immunol 2003; 50:232237.
  • 64
    Scarpelini F , Sbracia M : Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum Reprod 2009; 24:27032708.
  • 65
    Scott JR , Pattison N : Human chorionic gonadotropin for recurrent miscarriage. Cochrane Database Syst Rev 2005; 2:110. CD000101.
  • 66
    Schumacher A , Brachwitz N , Sohr S , Engeland K , Langwisch S , Dolaptchieva M , Alexander T , Taran A , Malfertheiner SF , Costa SD , Zimmermann G , Nitschke C , Volk HD , Alexander H , Gunzer M , Zenclussen AC : Human chorionic gonadotropin attracts regulatory T cells into the fetal-matemal interface during early human pregnancy. J Immunol 2009; 182:54885497.
  • 67
    Norris W , Nevers T , Sharma S , Kalkunte S : Review: hCG, preeclampsia and regulatory T cells. Placenta 2011; 32(Suppl 2):S182S185.
  • 68
    Wiwanitkit V : Predictive value of human chorionic gonadotrophin in the outcome of early pregnancy achieved by assisted reproductive technology: a summative assessment. J Hum Reprod Sci 2010; 3:161.
  • 69
    Rudensky A : Regulatory T cells get their chance to shine. Science 2011; 332:10201021.
  • 70
    Yang H , Qiu L , Di W , Zhao A , Chen G , Hu K , Lin Q : Proportional change of CD4+ CD25+ regulatory T cells after lymphocyte therapy in unexplained recurrent spontaneous abortion patients. Fertil Steril 2009; 92:301305.
  • 71
    Milojevic D , Nguyen KD , Wara D , Mellins ED : Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development. Pediatr Rheumatol 2008; 6:113.20.
  • 72
    Lidström C , Matthiesen LS , Berg G , Sharma S , Ernerudh J , Ekerfelt C : Cytokines secretion patterns of NK cells and macrophages in early human pregnant decidua and blood: implications for suppressor macrophages in decidua. Am J Reprod Immunol 2003; 50:444452.
  • 73
    Svensson J , Jenmalm MC , Matussek A , Geffers R , Berg G , Ernerudh J : Macrophages at the maternal fetal interface express markers of alternative activation and are induced by M-CSF and IL-10. J Immunol 2011; 187:36713682.
  • 74
    Hamilton JA : Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008; 8:533544.
  • 75
    Mosser DM , Zhang X : Interleukin-10: a new perspective of an old cytokine. Immunol Rev 2008; 226:205218.